Continuous Glucose Monitor (CGM) in Philadelphia, PA: When It Actually Helps

CGMs have become one of the most discussed tools in metabolic health. Some of the enthusiasm is earned: they catch dynamic glucose patterns that fasting glucose and HbA1c miss, they motivate behavior change, and they are clinically essential in insulin-using diabetes. Some of the enthusiasm is theater: the marketing of continuous lifetime CGM use to healthy adults outpaces the evidence that it changes outcomes. This page is the honest middle: where CGMs help in Philadelphia, where they do not, and how Fishtown Medicine uses them.

What CGMs measure

CGMs measure interstitial glucose (the glucose in the fluid between cells) every 1-5 minutes via a sensor worn on the upper arm or abdomen. Sensors are typically replaced every 10-14 days. Data streams to a smartphone app, where you can see real-time glucose, daily patterns, and how specific meals affect you. The data includes:

• Time-in-range. What percentage of the time your glucose is in a target range (typically 70-180 for diabetes, often 70-140 or tighter for non-diabetic use).
• Post-prandial peaks. How high glucose spikes after meals and how long it takes to come back down.
• Overnight patterns. Sometimes catches sleep-related hypoglycemia or dawn-phenomenon hyperglycemia.
• Glycemic variability. The standard deviation of glucose values; high variability correlates with worse metabolic outcomes.

CGMs in Philadelphia

Prescription CGMs: Dexcom G7, FreeStyle Libre 3, Medtronic systems. Available with prescription from any primary care practice. Insurance coverage is excellent for diabetes; for non-diabetic use, coverage varies. Over-the-counter CGMs: Stelo (Dexcom) and Lingo (Abbott) are now available without prescription in 2026, designed for the non-diabetic metabolic health market. Approximately $89 for a 30-day sensor pack. Local pharmacies (Walgreens, CVS, Rite Aid) typically stock at least one option. Mail-order pharmacy programs for diabetes-prescribed CGMs are also common.

When CGMs actually help (non-diabetic use)

The highest-value non-diabetic use cases:

• Suspected insulin resistance or prediabetes with normal fasting glucose. A 2-4 week CGM window catches post-prandial spikes that standard testing misses.
• PCOS or metabolic syndrome evaluation. The dynamic glucose pattern is more informative than fasting values.
• Weight-loss plateau evaluation. CGMs sometimes reveal specific foods or eating windows that are stalling progress.
• Patient motivation and behavior change. Seeing your glucose spike after specific foods often changes behavior more durably than verbal advice.
• Suspected hypoglycemia or dawn phenomenon when standard testing is inconclusive.

When CGMs are less useful:

• Asymptomatic metabolically healthy adults with normal HbA1c, normal fasting insulin, normal lipid panel, and no PCOS. Continuous data here is interesting but rarely changes clinical decisions.
• Patients with disordered eating histories. CGMs can drive restrictive behavior in some patients.
• Continuous lifetime use for healthy adults. A short diagnostic window followed by behavior change is usually sufficient.

How Fishtown Medicine uses CGMs

A 2-4 week diagnostic window is our default approach for non-diabetic patients. We typically order a single Dexcom or Libre sensor pack (or recommend a Stelo for self-purchase), have the patient wear it during a normal eating pattern, then meet to review the data together and design a behavior plan. Patients who benefit from longer-term monitoring (active diabetes management, weight loss with CGM motivation, complex insulin resistance) get extended use. For diabetes management, we follow standard practice: CGM is standard of care for type 1 and insulin-using type 2 diabetes.

What it costs

Membership at Fishtown Medicine is $250/month, $685/quarter, or $2,500/year. CGM interpretation and the behavior-change conversations are inside the membership. The sensors themselves are billed separately:

• Diabetes with insurance coverage: copays typically $25-100/month.
• Non-diabetic prescription use: insurance coverage variable.
• Over-the-counter Stelo or Lingo: $89/month or similar.

Key Takeaways

• CGMs are clinically essential for type 1 and insulin-using type 2 diabetes.
• For non-diabetic adults, a 2-4 week diagnostic window is usually more useful than continuous use.
• Over-the-counter options (Stelo, Lingo) make non-prescription access easier in 2026.
• Fishtown Medicine uses CGMs strategically for the right patient at the right time.

Related Services and Reading

• Metabolic Health in Philadelphia
• GLP-1 Weight Loss in Philadelphia
• PCOS Care in Philadelphia
• Metabolic Health Pillar
• Direct Primary Care in Philadelphia

---